New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
09:05 EDTHIMX, AKRX, GTAT, THC, SALE, MSI, BLMN, CAR, FIVN, CVS, GCI, COH, TGT, ODPOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Office Depot (ODP), up 6.9%... Coach (COH), up 4.3%... Akorn (AKRX), up 4.9%... Avis Budget (CAR), up 4.7%... GT Advanced (GTAT), up 3.7%... Tenet Healthcare (THC), up 1.9%... CVS Caremark (CVS), up 1.1%. HIGHER: Gannett (GCI), up 5.6% after acquiring remaining 73% interest in Classified Ventures for $1.8B, announcing plans to spin-off publishing business to shareholders... Himax (HIMX), up 4% after shares upgraded to Buy from Neutral at BofA Merrill Lynch. DOWN AFTER EARNINGS: Motorola Solutions (MSI), down 3.6%... Bloomin' Brands (BLMN), down 10.4%. LOWER: Target (TGT), down 4.6% after lowering its Q2 adjusted earnings per share view, updating on impact of data breach... RetailMeNot (SALE), down 20%, downgraded at RBC Capital following the company's Q2 report... Five9 (FIVN), down 22%, downgraded at Pacific Crest following lower than expected quarterly results.
News For TGT;GCI;ODP;COH;CVS;MSI;GTAT;FIVN;SALE;AKRX;CAR;THC;HIMX;BLMN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
January 22, 2015
09:01 EDTMSIMotorola Solutions invests in SceneDoc, terms not disclosed
Subscribe for More Information
08:44 EDTGCIGannett: Shareholder interest will remain company's priority
Subscribe for More Information
08:43 EDTGCIGannett says will evaluate Icahn's submission of precatory proposals
Subscribe for More Information
08:43 EDTGCIGannett responds to Icahn actions
Gannett Co. responded to an amended Form 13D filing by Carl Icahn and affiliates, who own approximately 6.6% of Gannett, disclosing nomination of two candidates for election to Gannett’s Board of Directors at Gannett’s 2015 Annual Shareholders’ Meeting. Icahn also disclosed submission of precatory proposals that would require certain corporate governance provisions at Gannett and at the new publishing company that will be formed upon completion of Gannett’s planned separation later this year. Gannett’s Board of Directors will evaluate the submission and make a recommendation to Gannett shareholders in due course. Marge Magner, non-executive chairman of Gannett’s Board, said, “We are surprised by Mr. Icahn’s aggressive actions, including his threat to run a proxy contest to force wholesale changes in Gannett’s corporate governance and dictate the corporate governance of a company whose governance profile has yet to be determined. His overreaching campaign to advance his own agenda will not deter the Board of Gannett from continuing to serve the interests of all of our shareholders. In addition to performing well, Gannett has a strong track record of shareholder engagement and sound corporate governance. As we execute on the separation of our publishing business this year, shareholder interests will remain our priority.” Gracia Martore, president and chief executive officer of Gannett, said, “Gannett is a shareholder-focused company that has consistently delivered strong returns for our owners. Since the launch of our strategic transformation plan three years ago, we have achieved significant revenue growth and margin expansion. During that same period, we have made attractive acquisitions to execute on our announced strategy, our stock price has more than doubled and total shareholder return has exceeded 265%, outpacing the S&P 500 and our peers by a wide margin.” Martore continued, “Our strong and independent Board has been a driving force behind our strategic transformation and our previously announced plan to separate into two publicly traded companies – a plan Mr. Icahn publicly supported following our announcement last summer and continues to support now.”
08:42 EDTGCIGannett says 'surprised' by Icahn's 'agressive' actions
Subscribe for More Information
08:38 EDTGCIIcahn to nominate two to Gannett board, asks for no poison pill
Subscribe for More Information
08:00 EDTGCIIcahn nominates two to Gannett board, CNBC's Faber reports
Subscribe for More Information
January 21, 2015
10:28 EDTCVSLeerink pharmaceuticals analyst holds an analyst/industry conference call
Subscribe for More Information
10:01 EDTCVSOn the Fly: Analyst Initiation Summary
Subscribe for More Information
10:01 EDTCVSOn the Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Ashford Hospitality (AHT) upgraded to Outperform from Neutral at Credit Suisse... BAE Systems (BAESY) upgraded to Buy from Neutral at Goldman... Bazaarvoice (BV) upgraded to Outperform from Market Perform at Cowen... Becton Dickinson (BDX) upgraded to Outperform at Cowen... CVS Health (CVS) upgraded to Buy from Neutral at Goldman... Camden Property (CPT) upgraded to Outperform from Neutral at Credit Suisse... ConocoPhillips (COP) upgraded to Buy from Neutral at BofA/Merrill... Cornerstone OnDemand (CSOD) upgraded to Buy from Neutral at DA Davidson... Cree (CREE) upgraded to Overweight at Stephens... DDR Corp. (DDR) upgraded to Outperform from Neutral at Credit Suisse... EastGroup Properties (EGP) upgraded to Outperform from Neutral at Credit Suisse... Energy Transfer Partners (ETP) upgraded to Outperform from Neutral at Credit Suisse... Esperion (ESPR) upgraded at BofA/Merrill... Exxon Mobil (XOM) upgraded to Outperform from Market Perform at Wells Fargo... FXCM (FXCM) upgraded to Market Perform from Underperform at Keefe Bruyette... Fair Isaac (FICO) upgraded to Overweight from Equal Weight at Barclays... Golar LNG (GLNG) upgraded to Buy from Hold at Nordea... Gran Tierra (GTE) upgraded to Buy at Canaccord... Host Hotels (HST) upgraded to Outperform from Neutral at Credit Suisse... J.M. Smucker (SJM) upgraded to Overweight from Neutral at JPMorgan... Kilroy Realty (KRC) upgraded to Neutral from Underperform at Credit Suisse... Level 3 (LVLT) upgraded to Outperform from Market Perform at Wells Fargo... Lowe's (LOW) upgraded to Overweight from Equal Weight at Morgan Stanley... Michael Kors (KORS) upgraded to Outperform at Cowen... Netflix (NFLX) upgraded at Nomura... Regions Financial (RF) upgraded to Buy from Neutral at Guggenheim... Ruckus Wireless (RKUS) upgraded to Outperform from Market Perform at Northland... Santander Mexico (BSMX) upgraded to Neutral from Underperform at Credit Suisse... Scorpio Tankers (STNG) upgraded to Buy at Canaccord... Sprouts Farmers Markets (SFM) upgraded to Buy from Neutral at BofA/Merrill... Strategic Hotels (BEE) upgraded to Outperform from Neutral at Credit Suisse... The Medicines Co. (MDCO) upgraded to Outperform from Market Perform at Leerink... Whole Foods (WFM) upgraded at Sterne Agee... Wolseley (WOSYY) upgraded to Neutral from Underperform at Exane BNP Paribas.
07:37 EDTCVSCVS Health initiated with an Overweight at Stephens
Subscribe for More Information
06:05 EDTCVSCVS Health upgraded to Buy from Neutral at Goldman
Goldman upgraded CVS to Buy based on strong leverage to Rx growth and Specialty, procurement savings upside, and capital deployment optionality. Price target raised to $113 from $95.
January 20, 2015
13:09 EDTODPSources: Staples to spurn Starboard's call to merge with Office Depot, FT says
Subscribe for More Information
10:47 EDTODPStaples says will consider 'all actions' that would create shareholder value
Subscribe for More Information
10:23 EDTODPStarboard says Staples should explore merger with Office Depot
Starboard Value, one of the largest shareholders of Staples (SPLS), confirmed, as previously reported, that it has delivered a letter to Ronald Sargent, Chairman and CEO of Staples, and the board of directors of Staples. In the letter, Starboard states in part: "As we discussed in our recent meeting, we believe that the best way to maximize value for Staples' shareholders is through exploring and completing a business combination with Office Depot (ODP). For a variety of reasons, we believe that now is the right time to pursue such a transaction, and we urge you to immediately retain a reputable investment bank and legal advisors to assist the Board in evaluating, structuring and executing a transaction with Office Depot. We believe that a strategic combination of Staples and Office Depot would result in synergies that would more than double the operating profits of the combined company and would create an industry-leading office supply retailer that could more effectively compete against larger retailers and online competitors. The magnitude of value creation from such a business combination far exceeds anything that either company could achieve on a standalone basis. We believe that the evidence is clear that shareholders are broadly supportive of a transaction between Staples and Office Depot. As shown in the chart below, since the merger speculation began last September, Staples' share price has risen over 50%, strongly outperforming the S&P 500...After the recent increase in Staples' share price, we believe the stock now trades at a substantial premium to the intrinsic value of the standalone company. This results in a lower cost of capital for Staples and a stronger currency which could be used to acquire Office Depot. If Staples fails to fully explore and consummate a transaction with Office Depot, shareholders will undoubtedly be extremely disappointed...We understand that this will require cooperation from Office Depot, and we have already expressed to them our strong support for a transaction...Our sincere hope is that we can continue to have a constructive dialogue. However, if it becomes clear to us that you have no intention of seriously pursuing this unique and highly attractive opportunity, it would be a clear sign that significant leadership change is needed at Staples."
09:44 EDTTGTSupreme Court denies appeal of 'swipe fee' ruling, Reuters reports
Subscribe for More Information
09:31 EDTODPActivist Starboard urging Staples, Office Depot to merge, WSJ reports
Subscribe for More Information
08:59 EDTODPStarboard urged Staples to explore Office Depot merger, Bloomberg says
Subscribe for More Information
08:09 EDTAKRXAkorn price target raised to $49 from $44 at Jefferies
Jefferies raised its price target for Akorn shares to $49 to reflect its FY15 estimates. The firm keeps a Buy rating on the stock.
07:11 EDTAKRXAkorn receives FDA approval for Phenylephrine Hydrochloride Ophthalmic Solution
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use